Edinburgh-based MiAlgae closed a round of £2.3m ($2.7M), which will help the company to build a commercial demonstrator plant by 2023.
The investment will support the company in its growth plans, including the completion of a commercial demonstrator facility near Stirling which will drive MiAlgae’s expanding commercial traction.
The investment will also help to grow the team at MiAlgae and increase its expertise, with ten new management appointments.
“It’s incredibly exciting to know that our investors see value in the biotechnology platform we’ve developed to tackle the production of omega-3 oils in a commercially viable way,” said Managing Director Douglas Martin.
The company is focused on the pet food sector with an eye on expansion into the aquaculture sector in the near future.
Established in 2016, MiAlgae has developed a novel biotechnology platform that uses low-value coproducts from the food and drink industry as a feedstock to initially grow microalgae rich in Omega-3 oils.
The latest articles
Interzoo 2024: what to expect
Just days before the European pet trade fair kicks off in Germany, GlobalPETS examines how it will unveil the latest trends in pet care.
General Mills scoops up Edgard & Cooper
The Belgian pet food manufacturer tells GlobalPETS that it aims to accelerate growth thanks to the American manufacturing giant’s supply chain expertise.
Partnership turns sour: Better Choice takes Alphia to court
Florida-based Better Choice started legal proceedings against American pet food manufacturer Alphia less than a year after investment.
Weekly newsletter to stay up-to-date
Discover what’s happening in the pet industry. Get the must-read stories and insights in your inbox.